Literature DB >> 15050490

Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall.

Takashi Oki1, Hideji Tanaka, Hirotsugu Yamada, Tomotsugu Tabata, Yoshifumi Oishi, Takeo Ishimoto, Norio Nagase, Hisanori Shinohara, Koichi Sakabe, Nobuo Fukuda.   

Abstract

The myocardial velocity profile (MVP), derived from color-coded tissue Doppler imaging (TDI), can identify transmural heterogeneity based on the physiology and pathology of the myocardium. This study sought to clarify whether the MVP can differentiate cardiac amyloidosis from other causes of left ventricular hypertrophy. We recorded the MVP and determined its myocardial velocity gradient (MVG) in the ventricular septum and left ventricular posterior wall using color-coded TDI in 10 patients with cardiac amyloidosis, in 25 patients with hypertensive hypertrophied left ventricular wall, in 25 patients with asymmetric septal hypertrophy of hypertrophic cardiomyopathy, and in 20 clinically normal controls. End-diastolic ventricular septal thickness was similar among the cardiac amyloidosis, hypertension, and hypertrophic cardiomyopathy groups. Percent systolic thickening of the ventricular septum and left ventricular posterior wall calculated from M-mode left ventricular echocardiograms was lower in the cardiac amyloidosis group than in the hypertension, hypertrophic cardiomyopathy, or control group. Peak MVGs during systole and early diastole were lowest in the cardiac amyloidosis group, followed, in order, by the control, hypertension, and hypertrophic cardiomyopathy groups. The systolic and early diastolic MVPs in the ventricular septum and left ventricular posterior wall showed a characteristic serrated pattern in all patients with cardiac amyloidosis, but not in any other patient groups. In conclusion, MVPs in the ventricular septum and left ventricular posterior wall show a distinctive serrated pattern that may be related to amyloid deposition in the myocardium. Myocardial tissue characterization using color-coded TDI provides diagnostic information in patients with cardiac amyloidosis.

Entities:  

Mesh:

Year:  2004        PMID: 15050490     DOI: 10.1016/j.amjcard.2003.12.025

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Echocardiographic evaluation of cardiac amyloid.

Authors:  Wendy Tsang; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

2.  The role of echocardiography in the non-invasive diagnosis of cardiac amyloidosis.

Authors:  Federico Cacciapuoti
Journal:  J Echocardiogr       Date:  2015-07-14

3.  Stiff heart syndrome.

Authors:  Satya S Bhupathi; Sreelatha Chalasani; Roxann Rokey
Journal:  Clin Med Res       Date:  2010-09-17

4.  Detection of early systolic dysfunction with strain rate imaging in a patient with light chain cardiomyopathy.

Authors:  A Niedeggen; O A Breithardt; A Franke
Journal:  Z Kardiol       Date:  2005-02

5.  Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study.

Authors:  Toru Kubo; Yuichi Baba; Takayoshi Hirota; Katsutoshi Tanioka; Naohito Yamasaki; Shigeo Yamanaka; Tatsuo Iiyama; Naoko Kumagai; Takashi Furuno; Tetsuro Sugiura; Hiroaki Kitaoka
Journal:  BMC Cardiovasc Disord       Date:  2015-06-16       Impact factor: 2.298

Review 6.  Striving towards the ideal cardiac functional assessment strategy: the contribution of tissue Doppler, strain and strain rate imaging.

Authors:  J C Mooman-Smook; P A Brink
Journal:  Cardiovasc J Afr       Date:  2007 Nov-Dec       Impact factor: 1.167

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.